Pseudocholinesterase deficiency is a genetic disorder associated with insufficient activity of the enzyme pseudocholinesterase, which plays a key role in the metabolism of certain drugs and neurotransmitters such as acetylcholine. Pseudocholinesterase, synthesized by the liver, is involved in the breakdown of acetylcholine in synapses, which is critical for maintaining normal nervous system function. Deficiency of this enzyme can lead to prolonged action of muscle relaxants and anesthetics, causing serious consequences such as prolonged muscle weakness and respiratory distress during general anesthesia. In this context, timely diagnosis and correct treatment are extremely important to prevent complications.
History of the disease and interesting historical facts
Pseudocholinesterase deficiency was first described in 1942, when researchers noticed that some patients failed to recover from anesthesia involving the muscle relaxant succinylcholine. Further research revealed that the cause was abnormally low activity of the enzyme pseudocholinesterase. Research in the 1950s found familial cases of the disorder, indicating that it was hereditary. In the decades that followed, various gene mutations responsible for the deficiency were identified, leading to genetic testing.
Epidemiology
Pseudocholinesterase deficiency is a rare genetic disorder. Its prevalence is estimated to range from 1 in 2,500 to 1 in 50,000 people, depending on the population. For example, the deficiency is more common in people of African and European descent, while cases are almost non-existent in some Asian regions. Given the hereditary nature of the disorder, cases may cluster in families, making it important to identify affected individuals to prevent serious complications during surgical interventions.
Genetic predisposition to this disease
Pseudocholinesterase deficiency is caused by mutations in the BCHE gene, located on chromosome 3. This gene codes for the synthesis of pseudocholinesterase. Studies have shown that there are several known polymorphisms of the gene, the most studied of which are the A-variant and E-variant mutations. Mutated alleles can increase the risk of developing enzyme deficiency and slow the metabolism of certain anesthetics, such as succinylcholine. Genetic testing can identify carriers of mutations and provide an opportunity for preliminary planning of anesthesia before surgical interventions.
Risk factors for the development of this disease
Although pseudocholinesterase deficiency is mostly an inherited disorder, there are several factors that may increase the risk of symptoms in predisposed individuals. These factors include:
- Genetic predisposition - the presence of cases of the disease in the family.
- Age - manifestations of the disease may be more pronounced at an older age.
- Use of certain medications—for example, muscle relaxants, especially succinylcholine.
- Environmental and dietary influences on metabolism - certain chemicals can affect enzymes in the liver.
Diagnosis of this disease
Diagnosis of pseudocholinesterase deficiency begins with a clinical examination that identifies symptoms such as prolonged muscle weakness and a prolonged recovery period from anesthesia. Laboratory tests play an important role in diagnosis and may include:
- Determination of pseudocholinesterase activity in blood serum, which allows to identify the degree of deficiency.
- Genetic testing to detect mutations in the BCHE gene in suspected patients.
- Analysis of the patient's medical history and list of medications taken by the patient to exclude acquired forms of the disorder.
It is important to conduct a differential diagnosis, excluding other causes of muscle relaxation and neurological disorders.
Treatment
Treatment for pseudocholinesterase deficiency focuses on preventing complications and adapting to the condition. Treatment approaches may include:
- General care and support - close monitoring of patients in the perioperative period.
- Pharmacological treatment, including specialized anesthetics that do not depend on the action of pseudocholinesterase.
- Informing the patient about the deficiency and its consequences before and after operations to prevent severe cases.
- In rare cases, surgery is required to correct associated disorders.
List of medications used to treat this disease
There is currently no specific treatment for pseudocholinesterase deficiency, but several medications are used to manage the condition:
- Rocuronium is a muscle relaxant that is independent of pseudocholinesterase.
- Vecuronium is safe for patients with pseudocholinesterase deficiency.
- Acetylcholine, which can be used in certain situations when needed.
Disease monitoring
Monitoring of a patient with pseudocholinesterase deficiency includes regular observation and assessment of muscle and respiratory function in the pre- and postoperative periods. The prognosis for patients with simple deficiency is favorable if the physicians are informed. However, if diagnosis is not made and anesthesia is improper, severe complications may occur, including respiratory distress, internal injuries, and even death.
Age-related features of the disease
Pseudocholinesterase deficiency can manifest itself differently depending on age. In infants and children, the deficiency may be less noticeable, while in adults and the elderly, symptoms are often more pronounced, which is associated with a general age-related decline in the functionality of organs and systems. In newborns, the deficiency may be barely noticeable, while in older patients, the risk of complications increases significantly.
Questions and Answers
- What is pseudocholinesterase deficiency? It is a genetic condition characterized by insufficient activity of the enzyme responsible for metabolizing acetylcholine and other substances, which can lead to long-term muscle weakness after anesthesia.
- How common is this disease? Pseudocholinesterase deficiency occurs with an incidence of 1 in 2,500 to 1 in 50,000, depending on ethnicity.
- How is pseudocholinesterase deficiency diagnosed? Diagnosis includes clinical observations, laboratory tests for enzyme activity, and genetic testing.
- What is the prognosis for patients with this disease? With adequate diagnosis and proper management of the condition, the prognosis is usually favorable, but if measures are not taken, serious complications may develop.
- Which medications are safe for patients with pseudocholinesterase deficiency? Muscle relaxants such as rocuronium and vecuronium are safe for use in these patients.
